RM

Robin M. Warren

DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, Stellenbosch University

Affiliated withStellenbosch University

Research Area

Biography

Robin M. Warren has not added Biography.
If you are Robin M. Warren and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 2
Year
Mycobacterial DNA Extraction using Bead Beating in Custom Buffer Followed by NGS Workflow
Publication title
2025
2026

Other Publications

Article
Year
Multiple Mycobacterium tuberculosis strains in early cultures from patients in a high-incidence community setting.

Journal of clinical microbiology| PubMed ID: 12149324

2002
2002
Patients with active tuberculosis often have different strains in the same sputum specimen.

American journal of respiratory and critical care medicine| PubMed ID: 14701710

2004
2004
2004
Transmission of tuberculosis in a high incidence urban community in South Africa.

International journal of epidemiology| PubMed ID: 15082639

2004
Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis.

American journal of respiratory and critical care medicine| PubMed ID: 15831840

2005
Reinfection and mixed infection cause changing Mycobacterium tuberculosis drug-resistance patterns.

American journal of respiratory and critical care medicine| PubMed ID: 15947286

2005
Recurrent culture-confirmed tuberculosis in human immunodeficiency virus-infected children.

The Pediatric infectious disease journal| PubMed ID: 16094221

2005
Drug resistance in Mycobacterium tuberculosis.

Current issues in molecular biology| PubMed ID: 16878362

2006
2006
Antimicrobial resistance in tuberculosis: an international perspective.

Expert review of anti-infective therapy| PubMed ID: 17140353

2006
2007
The role of IS6110 in the evolution of Mycobacterium tuberculosis.

Tuberculosis (Edinburgh, Scotland)| PubMed ID: 17627889

2007
2007
2007
2008
2008
2008
2008
2009
2009
2009
2010
2010
2010
2009
Novel Mycobacterium tuberculosis complex pathogen, M. mungi.

Emerging infectious diseases| PubMed ID: 20678329

2010
2020
2010
2011
2010
Rifampicin reduces susceptibility to ofloxacin in rifampicin-resistant Mycobacterium tuberculosis through efflux.

American journal of respiratory and critical care medicine| PubMed ID: 21512166

2011
2011
2012
Treatment outcomes of isoniazid-resistant tuberculosis patients, Western Cape Province, South Africa.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America| PubMed ID: 21810750

2011
Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa.

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases| PubMed ID: 21839855

2012
2011
2011
2012
2012
2012
2012
Characterization of Mycobacterium orygis.

Emerging infectious diseases| PubMed ID: 23017199

2012
2012
2012
Implementation of genotype MTBDRplus reduces time to multidrug-resistant tuberculosis therapy initiation in South Africa.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America| PubMed ID: 23090928

2013
2012
2013
2013
2013
Sulfatase-activated fluorophores for rapid discrimination of mycobacterial species and strains.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 23878250

2013
2013
2014
2013
2013
2013
2014
Novel cause of tuberculosis in meerkats, South Africa.

Emerging infectious diseases| PubMed ID: 24274183

2013
2013
Moxifloxacin retains antimycobacterial activity in the presence of gyrA mutations.

Antimicrobial agents and chemotherapy| PubMed ID: 24514091

2014
Energy metabolism and drug efflux in Mycobacterium tuberculosis.

Antimicrobial agents and chemotherapy| PubMed ID: 24614376

2014
The temporal dynamics of relapse and reinfection tuberculosis after successful treatment: a retrospective cohort study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America| PubMed ID: 24647020

2014
2014
2014
2014
2014
2015
2015
2015
Association of toll-like receptors with susceptibility to tuberculosis suggests sex-specific effects of TLR8 polymorphisms.

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases| PubMed ID: 26160538

2015
2015
2015
Efflux pump inhibitors: targeting mycobacterial efflux systems to enhance TB therapy.

The Journal of antimicrobial chemotherapy| PubMed ID: 26472768

2016
2015
Whole genome sequence analysis of Mycobacterium suricattae.

Tuberculosis (Edinburgh, Scotland)| PubMed ID: 26542221

2015
MDR tuberculosis control: time to change the dogma?

The Lancet. Respiratory medicine| PubMed ID: 26597129

2015
Genetic Determinants of Drug Resistance in Mycobacterium tuberculosis and Their Diagnostic Value.

American journal of respiratory and critical care medicine| PubMed ID: 26910495

2016
2016
2016
2016
2016
2016
Implementation of new tools for multidrug-resistant tuberculosis detection and control.

International journal of mycobacteriology| PubMed ID: 28043620

2016
2017
Implications of Failure to Routinely Diagnose Resistance to Second-Line Drugs in Patients With Rifampicin-Resistant Tuberculosis on Xpert MTB/RIF: A Multisite Observational Study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America| PubMed ID: 28199520

2017
2017
Progenitor strain introduction of Mycobacterium bovis at the wildlife-livestock interface can lead to clonal expansion of the disease in a single ecosystem.

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases| PubMed ID: 28412523

2017
2017
2017
2017
2017
2017
2017
2018
2018
Mycobacterial nucleoid associated proteins: An added dimension in gene regulation.

Tuberculosis (Edinburgh, Scotland)| PubMed ID: 29523320

2018
2018
2018
Drug-Penetration Gradients Associated with Acquired Drug Resistance in Patients with Tuberculosis.

American journal of respiratory and critical care medicine| PubMed ID: 29877726

2018
2018
2018
2018
2018
2018
2018
2018
2018
2018
2018
Transmission of drug-resistant tuberculosis in HIV-endemic settings.

The Lancet. Infectious diseases| PubMed ID: 30554996

2019
2018
2019
Spatial Network Mapping of Pulmonary Multidrug-Resistant Tuberculosis Cavities Using RNA Sequencing.

American journal of respiratory and critical care medicine| PubMed ID: 30694692

2019
2019
2019
2019
2019
2019
2019
Evolution of rifampicin treatment for tuberculosis.

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases| PubMed ID: 31247337

2019
Whole genome sequencing provides additional insights into recurrent tuberculosis classified as endogenous reactivation by IS6110 DNA fingerprinting.

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases| PubMed ID: 31276801

2019
2019
2019
2019
2019
2019
2019
2019
2019
2019
2019
2020
Minority Genotypic Populations as an Indicator of Subsequent Phenotypic Resistance.

American journal of respiratory cell and molecular biology| PubMed ID: 31774334

2019
2020
2020
2020
2020
2020
2020
Tuberculosis research in South Africa over the past 30 years: From bench to bedside.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde| PubMed ID: 32252868

2019
2020
2020
2020
2020
2021
2020
2020
2020
2021
2020
2021
Cytokine biomarker discovery in the white rhinoceros (Ceratotherium simum).

Veterinary immunology and immunopathology| PubMed ID: 33373875

2021
2022
Human whole genome sequencing in South Africa.

Scientific reports| PubMed ID: 33436733

2021
2021
2021
2021
Identification of gene fusion events in that encode chimeric proteins.

NAR genomics and bioinformatics| PubMed ID: 33575588

2020
2021
2021
2021
2021
2021
2021
Diagnostic accuracy of the FluoroType MTB and MTBDR VER 2.0 assays for the centralized high-throughput detection of Mycobacterium tuberculosis complex DNA and isoniazid and rifampicin resist...

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases| PubMed ID: 33933566

2021
2021
Alcohol and Tobacco Use in a Tuberculosis Treatment Cohort during South Africa's COVID-19 Sales Bans: A Case Series.

International journal of environmental research and public health| PubMed ID: 34069737

2021
2021
2021
Improved detection of and in African wildlife samples using cationic peptide decontamination and mycobacterial culture supplementation.

Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc| PubMed ID: 34510986

2022
2021
2021
2021
2022
2022
CYTOKINE-RELEASE ASSAY FOR THE DETECTION OF INFECTION IN CHEETAH ().

Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians| PubMed ID: 34998280

2021
2022
2022
2022
2022
2022
2022
2022
2022
2022
2023
2023
2023
2023
2023
2023
2023
2023
2023
2023
2023
2023
2023
2023
2024
2024
2024
2024
2024
Integrating molecular and radiological screening tools during community-based active case-finding for tuberculosis and COVID-19 in southern Africa.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases| PubMed ID: 38701914

2024
2024
2024
The Hidden Epidemic of Isoniazid-Resistant Tuberculosis in South Africa.

Annals of the American Thoracic Society| PubMed ID: 38935769

2024
2024
Bedaquiline: what might the future hold?

The Lancet. Microbe| PubMed ID: 39074472

2024
2024
2024
2024
2024
2024
2024
2024
2024
Patient Determinants and Effects on Adherence of Adverse Drug Reactions to Tuberculosis Treatment: A Prospective Cohort Analysis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America| PubMed ID: 39973802

2025
2025
Efficacy and Safety of Higher Doses of Levofloxacin for MDR-TB: A Randomized Placebo-controlled Phase 2 Trial.

American journal of respiratory and critical care medicine| PubMed ID: 40080768

2025
2025
2025
2025
2025